Intensity Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	65	117	-	-	-	-
Enterprise Value	55	103	3	-2	-9	-8
PE Ratio	-	-9.90	-	-	-	-
PB Ratio	6.70	8.93	-	-	-	-
P/FCF Ratio	-6.68	-16.31	-	-	-	-
P/OCF Ratio	-6.68	-16.31	-	-	-	-
EV/EBITDA Ratio	-4.50	-10.20	-0.41	0.28	1.49	1.54
EV/EBIT Ratio	-4.49	-10.05	-0.40	0.28	1.46	1.51
EV/FCF Ratio	-5.71	-14.27	-0.55	0.32	1.64	1.84
Debt / Equity Ratio	0.01	0.01	-0.29	-0.27	-0.32	-0.11
Debt / EBITDA Ratio	-0.01	-0.01	-0.59	-0.30	-0.08	-0.05
Debt / FCF Ratio	-0.01	-0.02	-0.79	-0.34	-0.09	-0.06
Quick Ratio	4.17	3.73	0.19	1.22	6.92	7.44
Current Ratio	4.43	3.91	0.21	1.27	7.04	7.67
Interest Coverage	-61.29	-33.55	-91.46	-	-	-
Return on Equity (ROE)	-112.20%	-168.00%	57.70%	138.00%	306.60%	-
Return on Assets (ROA)	-93.50%	-89.00%	-338.40%	-105.80%	-63.20%	-
Return on Capital (ROIC)	-119.84%	-62.55%	70.24%	126.37%	586.63%	268.26%
Earnings Yield	-23.23%	-10.10%	-	-	-	-
FCF Yield	-16.38%	-6.13%	-	-	-	-
Buyback Yield / Dilution	-302.03%	-152.67%	-	-0.02%	-0.19%	-
Total Shareholder Return	-302.03%	-152.67%	-	-0.02%	-0.19%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).